<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CTJ</journal-id>
<journal-id journal-id-type="hwp">spctj</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Trials</journal-id>
<journal-title>Clinical Trials</journal-title>
<issn pub-type="ppub">1740-7745</issn>
<issn pub-type="epub">1740-7753</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1740774513483934</article-id>
<article-id pub-id-type="publisher-id">10.1177_1740774513483934</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Adaptive adjustment of the randomization ratio using historical control data</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hobbs</surname><given-names>Brian P</given-names></name>
<xref ref-type="aff" rid="aff1-1740774513483934">a</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Carlin</surname><given-names>Bradley P</given-names></name>
<xref ref-type="aff" rid="aff2-1740774513483934">b</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sargent</surname><given-names>Daniel J</given-names></name>
<xref ref-type="aff" rid="aff3-1740774513483934">c</xref>
</contrib>
</contrib-group>
<aff id="aff1-1740774513483934">
<label>a</label>Department of Biostatistics, The University of Texas MD Anderson Cancer Center, TX, USA</aff>
<aff id="aff2-1740774513483934">
<label>b</label>Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA</aff>
<aff id="aff3-1740774513483934">
<label>c</label>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA</aff>
<author-notes>
<corresp id="corresp1-1740774513483934">Brian P Hobbs, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. Email: <email>bphobbs@mdanderson.org</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2013</year>
</pub-date>
<volume>10</volume>
<issue>3</issue>
<fpage>430</fpage>
<lpage>440</lpage>
<permissions>
<copyright-statement>© The Author(s), 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">The Society for Clinical Trials</copyright-holder>
</permissions>
<abstract>
<sec id="section1-1740774513483934">
<title>Background</title>
<p>Prospective trial design often occurs in the presence of ‘acceptable’ historical control data. Typically, these data are only utilized for treatment comparison in a posteriori retrospective analysis to estimate population-averaged effects in a random-effects meta-analysis.</p>
</sec>
<sec id="section2-1740774513483934">
<title>Purpose</title>
<p>We propose and investigate an adaptive trial design in the context of an actual randomized controlled colorectal cancer trial. This trial, originally reported by Goldberg <italic>et al.</italic>, succeeded a similar trial reported by Saltz <italic>et al.</italic>, and used a control therapy identical to that tested (and found beneficial) in the Saltz trial.</p>
</sec>
<sec id="section3-1740774513483934">
<title>Methods</title>
<p>The proposed trial implements an adaptive randomization procedure for allocating patients aimed at balancing total information (concurrent and historical) among the study arms. This is accomplished by assigning more patients to receive the novel therapy in the absence of strong evidence for heterogeneity among the concurrent and historical controls. Allocation probabilities adapt as a function of the effective historical sample size (EHSS), characterizing relative informativeness defined in the context of a piecewise exponential model for evaluating time to disease progression. Commensurate priors are utilized to assess historical and concurrent heterogeneity at interim analyses and to borrow strength from the historical data in the final analysis. The adaptive trial’s frequentist properties are simulated using the actual patient-level historical control data from the Saltz trial and the actual enrollment dates for patients enrolled into the Goldberg trial.</p>
</sec>
<sec id="section4-1740774513483934">
<title>Results</title>
<p>Assessing concurrent and historical heterogeneity at interim analyses and balancing total information with the adaptive randomization procedure lead to trials that on average assign more new patients to the novel treatment when the historical controls are unbiased or slightly biased compared to the concurrent controls. Large magnitudes of bias lead to approximately equal allocation of patients among the treatment arms. Using the proposed commensurate prior model to borrow strength from the historical data, after balancing total information with the adaptive randomization procedure, provides admissible estimators of the novel treatment effect with desirable bias-variance trade-offs.</p>
</sec>
<sec id="section5-1740774513483934">
<title>Limitations</title>
<p>Adaptive randomization methods in general are sensitive to population drift and more suitable for trials that initiate with gradual enrollment. Balancing information among study arms in time-to-event analyses is difficult in the presence of informative right-censoring.</p>
</sec>
<sec id="section6-1740774513483934">
<title>Conclusions</title>
<p>The proposed design could prove important in trials that follow recent evaluations of a control therapy. Efficient use of the historical controls is especially important in contexts where reliance on preexisting information is unavoidable because the control therapy is exceptionally hazardous, expensive, or the disease is rare.</p>
</sec>
</abstract>
</article-meta>
</front>
<body>
<sec id="section7-1740774513483934" sec-type="intro">
<title>Introduction</title>
<p>Adaptive designs of clinical trials facilitate mid-trial modifications based on interim information from internal or external sources. Recently, methods have been proposed to facilitate adaptivity for prospective modification of many trial features, including randomization [<xref ref-type="bibr" rid="bibr1-1740774513483934">1</xref>,<xref ref-type="bibr" rid="bibr2-1740774513483934">2</xref>]. Friedman <italic>et al.</italic> [<xref ref-type="bibr" rid="bibr3-1740774513483934">3</xref>] broadly refer to randomization methods that facilitate mid-trial adjustments to the allocation ratios as <italic>adaptive</italic>. Two types of adaptive randomization (AR) procedures are commonly implemented in clinical trials. <italic>Baseline AR</italic> designs are used to balance the study arms with respect to prognostic factors that are available at baseline [<xref ref-type="bibr" rid="bibr4-1740774513483934">4</xref>,<xref ref-type="bibr" rid="bibr5-1740774513483934">5</xref>]. By contrast, <italic>response-adaptive</italic> or <italic>outcome-adaptive</italic> designs were developed for the purpose of assigning more patients to more effective or safer treatment regimens based on interim data from an ongoing trial [<xref ref-type="bibr" rid="bibr6-1740774513483934">6</xref><xref ref-type="bibr" rid="bibr7-1740774513483934"/><xref ref-type="bibr" rid="bibr8-1740774513483934"/><xref ref-type="bibr" rid="bibr9-1740774513483934"/>–<xref ref-type="bibr" rid="bibr10-1740774513483934">10</xref>]. While Korn and Freidlin [<xref ref-type="bibr" rid="bibr11-1740774513483934">11</xref>] have questioned the usefulness of designs that use outcome-adaptive randomization for this purpose in the two-armed setting, the potential remains to benefit from adaptive designs that assign more new patients to learn about newer, less studied therapies in the presence of historical controls that satisfy Pocock’s [<xref ref-type="bibr" rid="bibr12-1740774513483934">12</xref>] six ‘acceptability’ criteria (p. 177). Such designs promise to enhance efficiency when implementing controlled clinical trials that follow recent evaluations of a control therapy by facilitating more precise estimates of the treatment effect. However, assumptions of exchangeability among the historical and concurrent control data may lead to poor frequentist operating characteristics and highly biased results.</p>
<p>In this article, we propose an adaptive analog of an actual randomized controlled colorectal cancer trial originally reported by Goldberg <italic>et al</italic>. [<xref ref-type="bibr" rid="bibr13-1740774513483934">13</xref>] that succeeded a similar trial reported by Saltz <italic>et al</italic>. [<xref ref-type="bibr" rid="bibr14-1740774513483934">14</xref>]. The Goldberg trial used as its control arm an identical treatment to that found superior in the Saltz trial. The proposed adaptive design is based on a randomization method that adapts as a function of the relative informativeness of the historical data for evaluating the endpoint of interest (in this case, time to disease progression (TTP)). Actual patient-level data from the Saltz trial (historical) and enrollment dates from the Goldberg trial (current) are used to simulate the proposed adaptive design’s frequentist properties. Historical data are formally incorporated into the Bayesian analysis of the Goldberg trial using commensurate priors [<xref ref-type="bibr" rid="bibr15-1740774513483934">15</xref>,<xref ref-type="bibr" rid="bibr16-1740774513483934">16</xref>] in the context of a piecewise exponential model [<xref ref-type="bibr" rid="bibr17-1740774513483934">17</xref>].</p>
<p>In the absence of strong evidence for heterogeneity among the historical and accumulating current controls, the proposed adaptive design assigns more new patients to learn more about novel therapies, thus attempting to impose balance between concurrent and historical information. After an initial stage of equal allocation, the allocation probability is adjusted as a function of the effective historical sample size (EHSS). EHSS is defined as a function of a measure of the degree to which estimates of model parameters are ‘shrunk’ toward their historical counterparts.</p>
<p>Designs such as this promise to be important in contexts where reliance on preexisting information is unavoidable, as occurs when the control therapy is exceptionally hazardous or expensive, or when the disease is rare. There are many subareas of oncology that could benefit from applications of these methodologies, including rare subtypes of sarcomas; rare progressions of renal cell carcinoma, such as advanced sarcomatoid; and pediatric brain tumors, such as choroid plexus carcinoma, medulloblastoma, and pontine glioma, to mention a few.</p>
<p>This article proceeds as follows. Section ‘Colon cancer trials’ describes the colorectal cancer clinical trials that motivated the research. Section ‘Effective historical sample size’ introduces the concept of EHSS in the context of Bayesian analysis. Section ‘Probability models’ introduces the probability models used to evaluate TTP in the proposed, adaptive trial. In section ‘Adaptive trial design’, we formulate our proposed alternative, adaptive design. Section ‘Simulations’ discusses the adaptive design’s frequentist properties. Finally, section ‘Discussion’ concludes and suggests avenues for further development.</p>
</sec>
<sec id="section8-1740774513483934">
<title>Colon cancer trials</title>
<p>The proposed adaptive design is motivated by two successive randomized controlled colorectal cancer clinical trials originally reported in studies of Goldberg <italic>et al.</italic> [<xref ref-type="bibr" rid="bibr13-1740774513483934">13</xref>] and Saltz <italic>et al.</italic> [<xref ref-type="bibr" rid="bibr14-1740774513483934">14</xref>]. The initial trial [<xref ref-type="bibr" rid="bibr14-1740774513483934">14</xref>] randomized 683 patients with previously untreated metastatic colorectal cancer between May 1996 and May 1998 to one of three regimens: irinotecan alone, irinotecan and bolus fluorouracil plus leucovorin (IFL), or a regimen of 5-fluorouracil and leucovorin (5FU/LV) (‘standard therapy’). IFL resulted in significantly longer TTP and overall survival than both irinotecan alone and 5FU/LV, and thus became the standard of care therapy. The subsequent trial [<xref ref-type="bibr" rid="bibr13-1740774513483934">13</xref>] compared two new (at the time) drug combinations in 795 patients with previously untreated metastatic colorectal cancer, randomized between May 1999 and April 2001. Patients in the first drug group received the current ‘standard therapy’, the IFL regimen identical to that used in the historical study. The second group received oxaliplatin and infused fluorouracil plus leucovorin (abbreviated as FOLFOX), while the third group received irinotecan and oxaliplatin (abbreviated as IROX); both of the latter two regimens were new as of the beginning of the second trial.</p>
<p>Historical control data from the Saltz trial appear to satisfy Pocock’s [<xref ref-type="bibr" rid="bibr12-1740774513483934">12</xref>] acceptability criteria. Less than 1 year elapsed in the time between the last patient enrolling into the Saltz trial and the first patient enrolling into the Goldberg trial. Both trials used identically defined IFL therapies, both trials used similar inclusion and exclusion criteria, and both used identical criteria to assess TTP. For example, inclusion required an Eastern Cooperative Oncology Group performance status (PS) of 2 or less. Exploratory data analysis suggests that the trials enrolled patients from comparable populations. The first, second, and third quartiles of the sum of the longest diameters (in cm) of up to nine tumors at baseline are 5.0, 8.5, and 12.8 in the Saltz trial and 4.7, 7.9, and 12.7 in the Goldberg trial; for age (in years), they are 54, 62, and 69 in the Saltz trial and 53, 61, and 69 in the Goldberg trial.</p>
<p>Our proposed adaptive trial compares TTP between the FOLFOX and IFL regimens. The historical controls consist of patients randomized to IFL in the Saltz study; the current data consist of patients randomized to IFL or FOLFOX in the Goldberg trial. For simplicity, we omit data from the irinotecan alone and 5FU/LV arms in the Saltz study, and the IROX arm in the Goldberg study. We consider only patients who had measurable tumors at baseline, bringing the total sample size to 643: 224 historical and 419 current observations. Among the current patients, there are 208 controls (IFL), and 211 patients are treated with the new regimen (FOLFOX).</p>
</sec>
<sec id="section9-1740774513483934">
<title>Effective historical sample size</title>
<p>Balancing information among treatment arms, as data accrue in an adaptive, controlled trial, requires interim assessment of the relative informativeness of the historical data. Before formulating our adaptive trial design, we briefly introduce the concept of EHSS in the context of Bayesian analysis, a concept that will be used in section ‘Adaptive trial design’ to adjust allocation probabilities among study arms for new patients enrolled thereafter, in the context of a hierarchical model. The concept of EHSS is related to the work of Morita <italic>et al</italic>. [<xref ref-type="bibr" rid="bibr18-1740774513483934">18</xref>], who considered effective sample sizes of parametric <italic>prior distributions</italic> for <italic>nonhierarchical</italic> models.</p>
<p>Let <inline-formula id="inline-formula1-1740774513483934">
<mml:math display="inline" id="math1-1740774513483934">
<mml:msub>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:math></inline-formula> denote the vector of outcomes for <inline-formula id="inline-formula2-1740774513483934">
<mml:math display="inline" id="math2-1740774513483934">
<mml:msub>
<mml:mi>n</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:math></inline-formula> patients assigned to the control therapy in the historical trial. Similarly, let <inline-formula id="inline-formula3-1740774513483934">
<mml:math display="inline" id="math3-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
</mml:math></inline-formula> denote the vector of outcomes for <inline-formula id="inline-formula4-1740774513483934">
<mml:math display="inline" id="math4-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:math></inline-formula> patients in the current trial. Let <inline-formula id="inline-formula5-1740774513483934">
<mml:math display="inline" id="math5-1740774513483934">
<mml:msub>
<mml:mi>θ</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:math></inline-formula> and <inline-formula id="inline-formula6-1740774513483934">
<mml:math display="inline" id="math6-1740774513483934">
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> denote analogous model parameters and <inline-formula id="inline-formula7-1740774513483934">
<mml:math display="inline" id="math7-1740774513483934">
<mml:mrow>
<mml:mi>L</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula8-1740774513483934">
<mml:math display="inline" id="math8-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mi>L</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula> denote the likelihood functions corresponding to the historical and current data, respectively, where <inline-formula id="inline-formula9-1740774513483934">
<mml:math display="inline" id="math9-1740774513483934">
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> is the parameter of interest. Let <inline-formula id="inline-formula10-1740774513483934">
<mml:math display="inline" id="math10-1740774513483934">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> denote a suitable noninformative prior distribution for <inline-formula id="inline-formula11-1740774513483934">
<mml:math display="inline" id="math11-1740774513483934">
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. If the historical information is ignored, inference proceeds with respect to the posterior distribution of <inline-formula id="inline-formula12-1740774513483934">
<mml:math display="inline" id="math12-1740774513483934">
<mml:mrow>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
</mml:math></inline-formula></p>
<p>
<disp-formula id="disp-formula1-1740774513483934">
<label>(1)</label>
<mml:math display="block" id="math13-1740774513483934">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi>q</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>∝</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>L</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula1-1740774513483934" xlink:href="10.1177_1740774513483934-eq1.tif"/>
</disp-formula>
</p>
<p>We refer to (1) as the ‘reference’ model.</p>
<p>Now consider borrowing strength from the historical data. We may model a conditional relationship between <inline-formula id="inline-formula13-1740774513483934">
<mml:math display="inline" id="math14-1740774513483934">
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula14-1740774513483934">
<mml:math display="inline" id="math15-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> by assuming a conditional prior distribution, <inline-formula id="inline-formula15-1740774513483934">
<mml:math display="inline" id="math16-1740774513483934">
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, that is dependent upon a hyperparameter, <inline-formula id="inline-formula16-1740774513483934">
<mml:math display="inline" id="math17-1740774513483934">
<mml:mrow>
<mml:mi>η</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, controlling the amount of cross-study borrowing. Let <inline-formula id="inline-formula17-1740774513483934">
<mml:math display="inline" id="math18-1740774513483934">
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msubsup>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> denote a noninformative prior distribution for <inline-formula id="inline-formula18-1740774513483934">
<mml:math display="inline" id="math19-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>. Inference proceeds with respect to the posterior distribution of <inline-formula id="inline-formula19-1740774513483934">
<mml:math display="inline" id="math20-1740774513483934">
<mml:mrow>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
</mml:mrow>
</mml:math></inline-formula> induced by the Bayesian model</p>
<p>
<disp-formula id="disp-formula2-1740774513483934">
<label>(2)</label>
<mml:math display="block" id="math21-1740774513483934">
<mml:mrow>
<mml:mi>q</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>∝</mml:mo>
<mml:mi>L</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:munder>
<mml:mo>∫</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:munder>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:msubsup>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msubsup>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>L</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mi>d</mml:mi>
<mml:msub>
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula2-1740774513483934" xlink:href="10.1177_1740774513483934-eq2.tif"/>
</disp-formula>
</p>
<p>Model (2) facilitates borrowing of strength via joint modeling of the historical and current data. Thus, we refer to model (2) as the ‘joint’ model.</p>
<p>Let <inline-formula id="inline-formula20-1740774513483934">
<mml:math display="inline" id="math22-1740774513483934">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula> denote the posterior precision of <inline-formula id="inline-formula21-1740774513483934">
<mml:math display="inline" id="math23-1740774513483934">
<mml:mrow>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
</mml:math></inline-formula> corresponding to inference under the reference model, <inline-formula id="inline-formula22-1740774513483934">
<mml:math display="inline" id="math24-1740774513483934">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>=</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>E</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
</mml:msub>
<mml:msup>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>E</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msup>
<mml:mo>]</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math></inline-formula>. Let <inline-formula id="inline-formula23-1740774513483934">
<mml:math display="inline" id="math25-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula> denote the posterior precision of <inline-formula id="inline-formula24-1740774513483934">
<mml:math display="inline" id="math26-1740774513483934">
<mml:mrow>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
</mml:mrow>
</mml:math></inline-formula> corresponding to inference under the joint model, <inline-formula id="inline-formula25-1740774513483934">
<mml:math display="inline" id="math27-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>E</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">{</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>E</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mo stretchy="false">}</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msup>
<mml:msup>
<mml:mrow>
<mml:mo stretchy="false">]</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math></inline-formula>. If the relationship among sample size and precision is reasonably linear under the reference model, then the rate of precision per patient may be approximated by <inline-formula id="inline-formula26-1740774513483934">
<mml:math display="inline" id="math28-1740774513483934">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo stretchy="false">/</mml:mo>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. Therefore, the effective sample size of the joint model’s posterior is approximately <inline-formula id="inline-formula27-1740774513483934">
<mml:math display="inline" id="math29-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi mathvariant="script">P</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula>, suggesting that a sensible functional relationship between joint posterior precision and EHSS follows as given</p>
<p>
<disp-formula id="disp-formula3-1740774513483934">
<label>(3)</label>
<mml:math display="block" id="math30-1740774513483934">
<mml:mrow>
<mml:mi>EHSS</mml:mi>
<mml:mo>≈</mml:mo>
<mml:mi>n</mml:mi>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>η</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi mathvariant="bold-italic">y</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula3-1740774513483934" xlink:href="10.1177_1740774513483934-eq3.tif"/>
</disp-formula>
</p>
<p>In this formulation, EHSS is approximately the effective sample size of the joint posterior minus the current sample size <inline-formula id="inline-formula28-1740774513483934">
<mml:math display="inline" id="math31-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. If the joint model leads to little gain in precision, then the EHSS is small. In contrast, relatively large gains in precision will produce large values of EHSS. Of note, the above formulation considers the case where <inline-formula id="inline-formula29-1740774513483934">
<mml:math display="inline" id="math32-1740774513483934">
<mml:mrow>
<mml:mi>θ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> is a scalar. Mapping relative gains in precision among multiple parameters into a single EHSS presents additional complexity. Our example adaptive colon cancer trial presents one approach for time-to-event analysis using a piecewise exponential likelihood with multiple baseline hazards.</p>
</sec>
<sec id="section10-1740774513483934">
<title>Probability models</title>
<p>Pocock [<xref ref-type="bibr" rid="bibr12-1740774513483934">12</xref>] proposed Bayesian models for borrowing of strength from historical controls for time-to-event data in the context of parametric exponential models. He suggested that inference should proceed with fixed ‘magnitudes’ of the historical bias, noting that one may wish to repeat the analysis with several alternative values expressing varying degrees of trust in the historical controls. For the case of one historical study, the general commensurate prior approach [<xref ref-type="bibr" rid="bibr15-1740774513483934">15</xref>] extends the approach of Pocock and proposes a set of prior distributions for estimating the magnitude of historical bias from the observed data in the context of fully hierarchical and empirical Bayesian analysis for parametric inference with exponential families.</p>
<sec id="section11-1740774513483934">
<title>Piecewise exponential likelihood</title>
<p>Let <inline-formula id="inline-formula30-1740774513483934">
<mml:math display="inline" id="math33-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold-italic">Y</mml:mi>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula31-1740774513483934">
<mml:math display="inline" id="math34-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold-italic">c</mml:mi>
</mml:mrow>
</mml:math></inline-formula> denote vectors containing time-to-event variables and right-censoring indicators for <inline-formula id="inline-formula32-1740774513483934">
<mml:math display="inline" id="math35-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:math></inline-formula> patients, respectively. We use a piecewise exponential model that assumes constant baseline hazards within finite partitions of the time axis. Such a flexible model accommodates numerous shapes of the baseline hazard over the partition intervals. Following the notation of Ibrahim <italic>et al.</italic> [<xref ref-type="bibr" rid="bibr17-1740774513483934">17</xref>] (p. 48), we partition the time axis into <inline-formula id="inline-formula33-1740774513483934">
<mml:math display="inline" id="math36-1740774513483934">
<mml:mrow>
<mml:mi>J</mml:mi>
<mml:mo>+</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:math></inline-formula> intervals, <inline-formula id="inline-formula34-1740774513483934">
<mml:math display="inline" id="math37-1740774513483934">
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo>,</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>J</mml:mi>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>J</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo>,</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>J</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi>∞</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> where <inline-formula id="inline-formula35-1740774513483934">
<mml:math display="inline" id="math38-1740774513483934">
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo><mml:mo>…</mml:mo>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>J</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:mi>∞</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, and <inline-formula id="inline-formula36-1740774513483934">
<mml:math display="inline" id="math39-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>J</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> denote the end of patient follow-up, the maximum possible time that a patient could be followed during the trial. For <inline-formula id="inline-formula37-1740774513483934">
<mml:math display="inline" id="math40-1740774513483934">
<mml:mrow>
<mml:mi>y</mml:mi>
</mml:mrow>
</mml:math></inline-formula> in the <italic>j</italic>th interval, <inline-formula id="inline-formula38-1740774513483934">
<mml:math display="inline" id="math41-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:mi>y</mml:mi>
<mml:mo>≤</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>, the model assumes a constant baseline hazard <inline-formula id="inline-formula39-1740774513483934">
<mml:math display="inline" id="math42-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&gt;</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi>J</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. Suppose <inline-formula id="inline-formula40-1740774513483934">
<mml:math display="inline" id="math43-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">x</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> is a vector of <inline-formula id="inline-formula41-1740774513483934">
<mml:math display="inline" id="math44-1740774513483934">
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
</mml:math></inline-formula> patient-specific baseline covariates, where <inline-formula id="inline-formula42-1740774513483934">
<mml:math display="inline" id="math45-1740774513483934">
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:math></inline-formula> indexes patient, and <inline-formula id="inline-formula43-1740774513483934">
<mml:math display="inline" id="math46-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">β</mml:mi>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>β</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>β</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi mathvariant="bold">p</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> is the corresponding vector of regression coefficients. Let <inline-formula id="inline-formula44-1740774513483934">
<mml:math display="inline" id="math47-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">λ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> denote the vector of baseline hazards, <inline-formula id="inline-formula45-1740774513483934">
<mml:math display="inline" id="math48-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">λ</mml:mi>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi mathvariant="bold">J</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. Within the <italic>j</italic>th time partition interval, the hazard for the <italic>i</italic>th patient is assumed to be <inline-formula id="inline-formula46-1740774513483934">
<mml:math display="inline" id="math49-1740774513483934">
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">x</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold">β</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi>exp</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">x</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi mathvariant="bold">i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi mathvariant="bold">β</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula>. Let <inline-formula id="inline-formula47-1740774513483934">
<mml:math display="inline" id="math50-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> denote the vector of model parameters <inline-formula id="inline-formula48-1740774513483934">
<mml:math display="inline" id="math51-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="bold">λ</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold">β</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. The <italic>i</italic>th patient’s full contribution to the likelihood is as follows</p>
<p>
<disp-formula id="disp-formula4-1740774513483934">
<label>(4)</label>
<mml:math display="block" id="math52-1740774513483934">
<mml:mrow>
<mml:mtable align="right" width="80%">
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>L</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mi>Y</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>J</mml:mi>
<mml:mo>+</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:munderover>
<mml:msup>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi>exp</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">x</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi mathvariant="bold">i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi mathvariant="bold">β</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>≤</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>c</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:mo>×</mml:mo>
<mml:mi>exp</mml:mi>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mo>−</mml:mo>
<mml:mi>I</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>≤</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>+</mml:mo>
<mml:munderover>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>l</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:munderover>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>l</mml:mi>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mi>exp</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">x</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi mathvariant="bold">β</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula4-1740774513483934" xlink:href="10.1177_1740774513483934-eq4.tif"/>
</disp-formula>
</p>
<p>The likelihood in (4) assumes that the ratio of hazards for two individuals is constant over time, and thus represents a proportional hazards model.</p>
</sec>
<sec id="section12-1740774513483934">
<title>Commensurate prior model</title>
<p>In this subsection, we formulate a commensurate prior model [<xref ref-type="bibr" rid="bibr15-1740774513483934">15</xref>] for the scenario presented by the motivating successive colon cancer trials, where historical data are available <italic>only</italic> for the control group. The general commensurate prior approach facilitates estimation of the extent to which analogous parameters from distinct data sources have similar (‘commensurate’) posteriors through the specification of a particular hierarchical model. Commensurate prior distributions center model parameters defined in the context of the likelihood for the current data at their historical counterparts. Hobbs <italic>et al.</italic> [<xref ref-type="bibr" rid="bibr15-1740774513483934">15</xref>] use sparsity-inducing spike-and-slab hyperpriors for the precision parameters to favor the concurrent information in the presence of heterogeneity.</p>
<p>Let <inline-formula id="inline-formula49-1740774513483934">
<mml:math display="inline" id="math53-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula50-1740774513483934">
<mml:math display="inline" id="math54-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">c</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> denote vectors of length <inline-formula id="inline-formula51-1740774513483934">
<mml:math display="inline" id="math55-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> containing time-to-event variables and right-censoring indicators for patients assigned to the current control therapy in the historical study. Let <inline-formula id="inline-formula52-1740774513483934">
<mml:math display="inline" id="math56-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold-italic">Y</mml:mi>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula53-1740774513483934">
<mml:math display="inline" id="math57-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold-italic">c</mml:mi>
</mml:mrow>
</mml:math></inline-formula> denote data from <inline-formula id="inline-formula54-1740774513483934">
<mml:math display="inline" id="math58-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:math></inline-formula> patients in the current trial. Furthermore, let <inline-formula id="inline-formula55-1740774513483934">
<mml:math display="inline" id="math59-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>d</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> denote an indicator of the novel treatment for the <italic>i</italic>th patient in the current trial, <inline-formula id="inline-formula56-1740774513483934">
<mml:math display="inline" id="math60-1740774513483934">
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. In this context, the hazard for a historical patient in the <italic>j</italic>th time partition interval is identical to the <italic>j</italic>th historical baseline hazard, <inline-formula id="inline-formula57-1740774513483934">
<mml:math display="inline" id="math61-1740774513483934">
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>. For the <italic>i</italic>th patient in the current trial, the <italic>j</italic>th baseline hazard, <inline-formula id="inline-formula58-1740774513483934">
<mml:math display="inline" id="math62-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>, is modified by novel treatment status, <inline-formula id="inline-formula59-1740774513483934">
<mml:math display="inline" id="math63-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>d</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>: <inline-formula id="inline-formula60-1740774513483934">
<mml:math display="inline" id="math64-1740774513483934">
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>d</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi>exp</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>d</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, where <inline-formula id="inline-formula61-1740774513483934">
<mml:math display="inline" id="math65-1740774513483934">
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> is the log acceleration factor corresponding to the novel treatment. Both historical and current baseline hazard parameters are defined with respect to a single partition of the time axis characterized by boundary points <inline-formula id="inline-formula62-1740774513483934">
<mml:math display="inline" id="math66-1740774513483934">
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo><mml:mo>…</mml:mo>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>J</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:mi>∞</mml:mi>
</mml:mrow>
</mml:math></inline-formula>.</p>
<p>To borrow strength from the historical controls, the commensurate prior approach can be applied by assuming a normal prior for the <italic>j</italic>th log baseline hazard, <inline-formula id="inline-formula63-1740774513483934">
<mml:math display="inline" id="math67-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, centered at its historical counterpart, <inline-formula id="inline-formula64-1740774513483934">
<mml:math display="inline" id="math68-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, with precision <inline-formula id="inline-formula65-1740774513483934">
<mml:math display="inline" id="math69-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>: <inline-formula id="inline-formula66-1740774513483934">
<mml:math display="inline" id="math70-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>~</mml:mo>
<mml:mi>N</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">/</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. Given no additional prior information about the historical baseline hazards or novel treatment effect, inference may proceed with noninformative Gaussian prior distributions for the <inline-formula id="inline-formula67-1740774513483934">
<mml:math display="inline" id="math71-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>s</mml:mi>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula68-1740774513483934">
<mml:math display="inline" id="math72-1740774513483934">
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. Let <inline-formula id="inline-formula69-1740774513483934">
<mml:math display="inline" id="math73-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula70-1740774513483934">
<mml:math display="inline" id="math74-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> denote the current and historical data: <inline-formula id="inline-formula71-1740774513483934">
<mml:math display="inline" id="math75-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="bold-italic">Y</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">d</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">c</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula72-1740774513483934">
<mml:math display="inline" id="math76-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">c</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, respectively. Let <inline-formula id="inline-formula73-1740774513483934">
<mml:math display="inline" id="math77-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> denote the parameter vector <inline-formula id="inline-formula74-1740774513483934">
<mml:math display="inline" id="math78-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi>ξ</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>J</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula>, let <inline-formula id="inline-formula75-1740774513483934">
<mml:math display="inline" id="math79-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> denote the parameter vector <inline-formula id="inline-formula76-1740774513483934">
<mml:math display="inline" id="math80-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>J</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula>, and let <inline-formula id="inline-formula77-1740774513483934">
<mml:math display="inline" id="math81-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">τ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> denote vector <inline-formula id="inline-formula78-1740774513483934">
<mml:math display="inline" id="math82-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">τ</mml:mi>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>τ</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mi>τ</mml:mi>
<mml:mi>J</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. Following from (4), the joint posterior distribution of <inline-formula id="inline-formula79-1740774513483934">
<mml:math display="inline" id="math83-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="bold">τ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> is proportional to</p>
<p>
<disp-formula id="disp-formula5-1740774513483934">
<label>(5)</label>
<mml:math display="block" id="math84-1740774513483934">
<mml:mrow>
<mml:mtable align="right" width="80%">
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:mi>q</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="bold">τ</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>∝</mml:mo>
<mml:mi>N</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:munderover>
<mml:msub>
<mml:mi>L</mml:mi>
<mml:mi>Y</mml:mi>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:munder>
<mml:mo>∫</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:munder>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>J</mml:mi>
</mml:mrow>
</mml:munderover>
<mml:mi>N</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">/</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:mo>×</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi>N</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>k</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:munderover>
<mml:msub>
<mml:mrow>
<mml:mi>L</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>Y</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>d</mml:mi>
<mml:msub>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula5-1740774513483934" xlink:href="10.1177_1740774513483934-eq5.tif"/></disp-formula>
</p>
<p>where <inline-formula id="inline-formula80-1740774513483934">
<mml:math display="inline" id="math85-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>L</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">|</mml:mo>
<mml:mo>·</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> denotes the likelihood function corresponding to the piecewise exponential model for the historical data.</p>
<p>Following Hobbs <italic>et al</italic>. [<xref ref-type="bibr" rid="bibr15-1740774513483934">15</xref>], we assume ‘spike-and-slab’ prior distributions [<xref ref-type="bibr" rid="bibr19-1740774513483934">19</xref>] for the <inline-formula id="inline-formula81-1740774513483934">
<mml:math display="inline" id="math86-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi>s</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. This sparsity-inducing prior distribution is locally uniform between two limits, <inline-formula id="inline-formula82-1740774513483934">
<mml:math display="inline" id="math87-1740774513483934">
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>≤</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>u</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> except for a bit of probability mass concentrated at a point <inline-formula id="inline-formula83-1740774513483934">
<mml:math display="inline" id="math88-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="script">K</mml:mi>
<mml:mo>&gt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>u</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula></p>
<p>
<disp-formula id="disp-formula6-1740774513483934">
<label>(6)</label>
<mml:math display="block" id="math89-1740774513483934">
<mml:mrow>
<mml:mtable align="right" width="80%">
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:mi>Pr</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:mi>u</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>u</mml:mi>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo stretchy="false">/</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>u</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mo>,</mml:mo>
<mml:mspace width="0.25em"/>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>≤</mml:mo>
<mml:mi>u</mml:mi>
<mml:mo>≤</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>u</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mspace width="0.25em"/>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:mtext>and</mml:mtext>
<mml:mspace width="0.25em"/>
<mml:mi>Pr</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&gt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>u</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula6-1740774513483934" xlink:href="10.1177_1740774513483934-eq6.tif"/>
</disp-formula>
</p>
<p>The additional hyperparameter, <inline-formula id="inline-formula84-1740774513483934">
<mml:math display="inline" id="math90-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>, denotes the prior probability of the existence within the slab, that is, <inline-formula id="inline-formula85-1740774513483934">
<mml:math display="inline" id="math91-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>≤</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>≤</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>u</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>. Given <inline-formula id="inline-formula86-1740774513483934">
<mml:math display="inline" id="math92-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula87-1740774513483934">
<mml:math display="inline" id="math93-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="script">K</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, smaller values of <inline-formula id="inline-formula88-1740774513483934">
<mml:math display="inline" id="math94-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>u</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> impose more borrowing of strength from the historical information, requiring more evidence for heterogeneity to overcome the prior probability mass assigned to the spike, <inline-formula id="inline-formula89-1740774513483934">
<mml:math display="inline" id="math95-1740774513483934">
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>. The aforementioned authors [<xref ref-type="bibr" rid="bibr15-1740774513483934">15</xref>] show that this prior, when properly calibrated, leads to desirable bias-variance trade-offs for estimating concurrent effects in the context of commensurate prior models for exponential families. The results of our simulation study discussed in section ‘Simulations’ illustrate the advantages of the spike-and-slab commensurate prior model in this context. Markov chain Monte Carlo (MCMC) methods can be used to sample from the joint posterior model (5).</p>
</sec>
</sec>
<sec id="section13-1740774513483934">
<title>Adaptive trial design</title>
<p>In this section, we formulate our proposed alternative design of the Goldberg trial following completion of the Saltz trial, which uses permuted-block randomization in both nonadaptive and adaptive phases. During the initial, nonadaptive phase, new patients are allocated equally between the control (IFL) and novel (FOLFOX) treatments until a targeted number of events selected to ensure that sufficient information has accrued to assess heterogeneity among the concurrent and historical controls. Thereafter, the treatment allocation probability is adjusted as a function of the EHSS and the number of patients assigned to each regimen. We use the piecewise exponential commensurate prior model (5) to jointly model the concurrent and historical data at each interim analysis. Given large EHSS, the adaptive design will randomize more new patients to the newer, less studied therapy.</p>
<sec id="section14-1740774513483934">
<title>Historical data</title>
<p>We use likelihood inference based on (4) to select the time axis partition for the full Bayesian analysis of the historical control data alone. The Akaike information criterion (AIC) optimal partition contains two intervals with boundary point at <inline-formula id="inline-formula90-1740774513483934">
<mml:math display="inline" id="math96-1740774513483934">
<mml:mrow>
<mml:mi>s</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>243</mml:mn>
<mml:mspace width="0.25em"/>
<mml:mtext>days</mml:mtext>
</mml:mrow>
</mml:math></inline-formula>.</p>
<p>Thus, the piecewise exponential model contains two parameters characterizing baseline hazards within intervals <inline-formula id="inline-formula91-1740774513483934">
<mml:math display="inline" id="math97-1740774513483934">
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>243</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula92-1740774513483934">
<mml:math display="inline" id="math98-1740774513483934">
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mn>243</mml:mn>
<mml:mo>,</mml:mo>
<mml:mo>max</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, respectively. <xref ref-type="fig" rid="fig1-1740774513483934">Figure 1</xref> contains the associated TTP curves. The dashed line represents the Kaplan–Meier curve, while dotted lines correspond to associated 95% log-transformed [<xref ref-type="bibr" rid="bibr20-1740774513483934">20</xref>] (p. 105) pointwise confidence intervals. Results for the piecewise exponential analysis are plotted with a solid line. Posterior summaries corresponding to the Bayesian analysis are provided in <xref ref-type="table" rid="table1-1740774513483934">Table 1</xref>. The posterior mean of median survival is approximately 205 days.</p>
<fig id="fig1-1740774513483934" position="float">
<label>Figure 1.</label>
<caption>
<p>Time to disease progression for patients assigned to IFL in the Saltz trial: Kaplan–Meier curve (dashed), piecewise exponential curve (solid), 95% log-transformed pointwise confidence intervals (dotted). Right-censored observations are marked by +.</p>
<p>IFL: Irinotecan and fluorouracil plus leucovorin; TTP: time to disease progression.</p>
</caption>
<graphic xlink:href="10.1177_1740774513483934-fig1.tif"/>
</fig>
<table-wrap id="table1-1740774513483934" position="float">
<label>Table 1.</label>
<caption>
<p>Posterior means and SDs derived from the piecewise exponential analysis of time to disease progression for patients randomized to IFL in the Saltz trial, <inline-formula id="inline-formula93-1740774513483934">
<mml:math display="inline" id="math99-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mn>224</mml:mn>
</mml:mrow>
</mml:math></inline-formula>.</p>
</caption>
<graphic alternate-form-of="table1-1740774513483934" xlink:href="10.1177_1740774513483934-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">Mean</th>
<th align="left">SD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Log baseline hazard 1</td>
<td>
<inline-formula id="inline-formula94-1740774513483934">
<mml:math display="inline" id="math100-1740774513483934">
<mml:mrow>
<mml:mo>−</mml:mo>
<mml:mn>5</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>689</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td>
<inline-formula id="inline-formula95-1740774513483934">
<mml:math display="inline" id="math101-1740774513483934">
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>094</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
</tr>
<tr>
<td>Log baseline hazard 2</td>
<td>
<inline-formula id="inline-formula96-1740774513483934">
<mml:math display="inline" id="math102-1740774513483934">
<mml:mrow>
<mml:mo>−</mml:mo>
<mml:mn>4</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>858</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td>
<inline-formula id="inline-formula97-1740774513483934">
<mml:math display="inline" id="math103-1740774513483934">
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>133</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1740774513483934">
<p>SD: standard deviation; IFL: irinotecan and fluorouracil plus leucovorin.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section15-1740774513483934">
<title>New trial</title>
<p>The Goldberg trial actually enrolled a total of <inline-formula id="inline-formula98-1740774513483934">
<mml:math display="inline" id="math104-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>419</mml:mn>
</mml:mrow>
</mml:math></inline-formula> patients with measurable tumors assigned to either IFL (control) or FOLFOX (novel treatment) regimens. <xref ref-type="fig" rid="fig2-1740774513483934">Figure 2</xref> plots actual enrollment over time. Each enrollment is characterized by a dot representing the trial’s cumulative sample size (<italic>y</italic>-axis) in calendar time (<italic>x</italic>-axis). The first patient was enrolled on 20 May 1999, the last patient was enrolled on 25 April 2001. We use the Goldberg <italic>et al</italic>. [<xref ref-type="bibr" rid="bibr13-1740774513483934">13</xref>] article’s submission date as the time of final analysis, which occurred approximately 28 months after close of enrollment.</p>
<fig id="fig2-1740774513483934" position="float">
<label>Figure 2.</label>
<caption>
<p>Enrollment over time for patients randomized to the FOLFOX or IFL regimens in the Goldberg trial. The <italic>y</italic>-axis represents cumulative sample size. The <italic>x</italic>-axis represents calendar time.</p>
<p>IFL: irinotecan and fluorouracil plus leucovorin; FOLFOX: oxaliplatin and infused fluorouracil plus leucovorin.</p>
</caption>
<graphic xlink:href="10.1177_1740774513483934-fig2.tif"/>
</fig>
<p>Our proposed trial consists of two phases. During the first, nonadaptive phase, patients are randomized 1:1 to the treatment regimens until <inline-formula id="inline-formula99-1740774513483934">
<mml:math display="inline" id="math105-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> events are observed. In order to ensure periodic balance in the number of patients assigned to each regimen, permuted-block randomization [<xref ref-type="bibr" rid="bibr21-1740774513483934">21</xref>] is used with blocks of size 2 patients. An initial interim analysis to assess historical and concurrent control heterogeneity and compute EHSS will occur at that time. An adaptive, permuted-block randomization procedure that is a function of EHSS will be used to assign new patients to treatment arms thereafter in blocks of size <inline-formula id="inline-formula100-1740774513483934">
<mml:math display="inline" id="math106-1740774513483934">
<mml:mrow>
<mml:mi>B</mml:mi>
</mml:mrow>
</mml:math></inline-formula> patients. EHSS will be reassessed after every <italic>B</italic>th enrollment. The final analysis, using the joint model, occurs 51 months after the trial’s initiation. <inline-formula id="inline-formula101-1740774513483934">
<mml:math display="inline" id="math107-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> needs to be large enough so that sufficient information to assess control heterogeneity has accrued, yet small enough to justify the adaptive treatment allocation. In practice, <inline-formula id="inline-formula102-1740774513483934">
<mml:math display="inline" id="math108-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula103-1740774513483934">
<mml:math display="inline" id="math109-1740774513483934">
<mml:mrow>
<mml:mi>B</mml:mi>
</mml:mrow>
</mml:math></inline-formula> should be selected in the context of a comprehensive assessment of the trial’s operating characteristics in the presence of the historical data and expected patient enrollment. Our simulation study, discussed in the section ‘Simulations’, considers frequentist properties of the adaptive design under three different values of <inline-formula id="inline-formula104-1740774513483934">
<mml:math display="inline" id="math110-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>.</p>
<sec id="section16-1740774513483934">
<title>Data structure</title>
<p>Let <inline-formula id="inline-formula105-1740774513483934">
<mml:math display="inline" id="math111-1740774513483934">
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1552</mml:mn>
</mml:mrow>
</mml:math></inline-formula> denote the time of the trial’s final analysis in days. Let <inline-formula id="inline-formula106-1740774513483934">
<mml:math display="inline" id="math112-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula> denote ‘trial time’, <inline-formula id="inline-formula107-1740774513483934">
<mml:math display="inline" id="math113-1740774513483934">
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>&lt;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo>&lt;</mml:mo>
<mml:mi>T</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, and let <inline-formula id="inline-formula108-1740774513483934">
<mml:math display="inline" id="math114-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>, <inline-formula id="inline-formula109-1740774513483934">
<mml:math display="inline" id="math115-1740774513483934">
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:mn>706</mml:mn>
</mml:mrow>
</mml:math></inline-formula>, represent the time at which the <italic>i</italic>th patient enrolls. Let <inline-formula id="inline-formula110-1740774513483934">
<mml:math display="inline" id="math116-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> denote the random variable containing the value of the <italic>i</italic>th patient’s TTP process at time <inline-formula id="inline-formula111-1740774513483934">
<mml:math display="inline" id="math117-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. Note that <inline-formula id="inline-formula112-1740774513483934">
<mml:math display="inline" id="math118-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> is recorded from <inline-formula id="inline-formula113-1740774513483934">
<mml:math display="inline" id="math119-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>, so that <inline-formula id="inline-formula114-1740774513483934">
<mml:math display="inline" id="math120-1740774513483934">
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>&lt;</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>. Let <inline-formula id="inline-formula115-1740774513483934">
<mml:math display="inline" id="math121-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold-italic">Y</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula> denote the vector of values of the TTP processes for the <inline-formula id="inline-formula116-1740774513483934">
<mml:math display="inline" id="math122-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> patients enrolled prior to time <inline-formula id="inline-formula117-1740774513483934">
<mml:math display="inline" id="math123-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, <inline-formula id="inline-formula118-1740774513483934">
<mml:math display="inline" id="math124-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:munderover>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:munderover>
<mml:mi>I</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&lt;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, where <inline-formula id="inline-formula119-1740774513483934">
<mml:math display="inline" id="math125-1740774513483934">
<mml:mrow>
<mml:mi>I</mml:mi>
</mml:mrow>
</mml:math></inline-formula> is the indicator function. Let <inline-formula id="inline-formula120-1740774513483934">
<mml:math display="inline" id="math126-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>c</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> denote an indicator of the <italic>i</italic>th patient’s right-censoring status at time <inline-formula id="inline-formula121-1740774513483934">
<mml:math display="inline" id="math127-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, and let <inline-formula id="inline-formula122-1740774513483934">
<mml:math display="inline" id="math128-1740774513483934">
<mml:mrow>
<mml:mi>c</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>c</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>c</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula> denote the vector of values of censoring processes for the <inline-formula id="inline-formula123-1740774513483934">
<mml:math display="inline" id="math129-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> patients enrolled prior to time <inline-formula id="inline-formula124-1740774513483934">
<mml:math display="inline" id="math130-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. Finally, let <inline-formula id="inline-formula125-1740774513483934">
<mml:math display="inline" id="math131-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>d</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> denote a treatment indicator for the <italic>i</italic>th patient, with ‘0’ indicating IFL and ‘1’ indicating FOLFOX, and let <inline-formula id="inline-formula126-1740774513483934">
<mml:math display="inline" id="math132-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold-italic">d</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">{</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>d</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>d</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">}</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. Denote concurrent data at time <inline-formula id="inline-formula127-1740774513483934">
<mml:math display="inline" id="math133-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula> by <inline-formula id="inline-formula128-1740774513483934">
<mml:math display="inline" id="math134-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi mathvariant="bold-italic">Y</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">c</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi mathvariant="bold-italic">d</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula> and historical data by <inline-formula id="inline-formula129-1740774513483934">
<mml:math display="inline" id="math135-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">c</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>.</p>
</sec>
<sec id="section17-1740774513483934">
<title>Posterior inference</title>
<p>The piecewise exponential models used for analysis at time <inline-formula id="inline-formula130-1740774513483934">
<mml:math display="inline" id="math136-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula> contain two baseline hazard parameters, <inline-formula id="inline-formula131-1740774513483934">
<mml:math display="inline" id="math137-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula132-1740774513483934">
<mml:math display="inline" id="math138-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>, corresponding to intervals <inline-formula id="inline-formula133-1740774513483934">
<mml:math display="inline" id="math139-1740774513483934">
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>m</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula134-1740774513483934">
<mml:math display="inline" id="math140-1740774513483934">
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mi>m</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">]</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, where <inline-formula id="inline-formula135-1740774513483934">
<mml:math display="inline" id="math141-1740774513483934">
<mml:mrow>
<mml:mi>m</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> denotes the median TTP among the concurrent events observed by time <inline-formula id="inline-formula136-1740774513483934">
<mml:math display="inline" id="math142-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. This balances the available concurrent information between the two partition intervals at each analysis. Following the notation of section ‘Probability models’, let <inline-formula id="inline-formula137-1740774513483934">
<mml:math display="inline" id="math143-1740774513483934">
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> denote the FOLFOX effect, and let <inline-formula id="inline-formula138-1740774513483934">
<mml:math display="inline" id="math144-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula139-1740774513483934">
<mml:math display="inline" id="math145-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> denote the current and historical parameter vectors, where <inline-formula id="inline-formula140-1740774513483934">
<mml:math display="inline" id="math146-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi>ξ</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula>, and <inline-formula id="inline-formula141-1740774513483934">
<mml:math display="inline" id="math147-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula>.</p>
<p>The reference model (1) in this context consists of the Bayesian piecewise exponential model that estimates <inline-formula id="inline-formula142-1740774513483934">
<mml:math display="inline" id="math148-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> in the absence of the historical controls. It assumes noninformative Gaussian prior distributions (with small precision <inline-formula id="inline-formula143-1740774513483934">
<mml:math display="inline" id="math149-1740774513483934">
<mml:mrow>
<mml:mi>w</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>01</mml:mn>
</mml:mrow>
</mml:math></inline-formula>) for the FOLFOX effect, <inline-formula id="inline-formula144-1740774513483934">
<mml:math display="inline" id="math150-1740774513483934">
<mml:mrow>
<mml:mi>ξ</mml:mi>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math></inline-formula> and the log baseline hazards, <inline-formula id="inline-formula145-1740774513483934">
<mml:math display="inline" id="math151-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula146-1740774513483934">
<mml:math display="inline" id="math152-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. At trial time <inline-formula id="inline-formula147-1740774513483934">
<mml:math display="inline" id="math153-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, the posterior distribution of <inline-formula id="inline-formula148-1740774513483934">
<mml:math display="inline" id="math154-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> under the reference model follows from (4) as</p>
<p>
<disp-formula id="disp-formula7-1740774513483934">
<label>(7)</label>
<mml:math display="block" id="math155-1740774513483934">
<mml:mrow>
<mml:mtable align="right" width="80%">
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi>q</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>∝</mml:mo>
<mml:mi>N</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">/</mml:mo>
<mml:mi>w</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:munderover>
<mml:mi>N</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">/</mml:mo>
<mml:mi>w</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:munderover>
<mml:msub>
<mml:mrow>
<mml:mi>L</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula7-1740774513483934" xlink:href="10.1177_1740774513483934-eq7.tif"/>
</disp-formula>
</p>
<p>The joint model (2) consists of a commensurate prior model (5) that borrows strength from the historical control data for estimating <inline-formula id="inline-formula149-1740774513483934">
<mml:math display="inline" id="math156-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. Following from (4), (5), and (6), the posterior distribution of <inline-formula id="inline-formula150-1740774513483934">
<mml:math display="inline" id="math157-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> under the joint model at trial time <inline-formula id="inline-formula151-1740774513483934">
<mml:math display="inline" id="math158-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula> is</p>
<p>
<disp-formula id="disp-formula8-1740774513483934">
<label>(8)</label>
<mml:math display="block" id="math159-1740774513483934">
<mml:mrow>
<mml:mtable align="right" width="80%">
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:mi>q</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>∝</mml:mo>
<mml:mi>N</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">/</mml:mo>
<mml:mi>w</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:munderover>
<mml:msub>
<mml:mrow>
<mml:mi>L</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:mo>×</mml:mo>
<mml:munder>
<mml:mo>∫</mml:mo>
<mml:mrow>
<mml:mi mathvariant="bold">τ</mml:mi>
</mml:mrow>
</mml:munder>
<mml:munder>
<mml:mo>∫</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="bold">θ</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
</mml:munder>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:munderover>
<mml:mi>N</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">/</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>N</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">/</mml:mo>
<mml:mi>w</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>k</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:munderover>
<mml:msub>
<mml:mrow>
<mml:mi>L</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>d</mml:mi>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold">θ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mi>d</mml:mi>
<mml:mi mathvariant="bold">τ</mml:mi>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula8-1740774513483934" xlink:href="10.1177_1740774513483934-eq8.tif"/></disp-formula>
</p>
<p>where <inline-formula id="inline-formula152-1740774513483934">
<mml:math display="inline" id="math160-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>u</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> denotes the spike-and-slab prior distribution in (6) evaluated at <inline-formula id="inline-formula153-1740774513483934">
<mml:math display="inline" id="math161-1740774513483934">
<mml:mrow>
<mml:mi>u</mml:mi>
</mml:mrow>
</mml:math></inline-formula>.</p>
</sec>
<sec id="section18-1740774513483934">
<title>Effective number of historical controls and adaptive randomization</title>
<p>We compute EHSS at interim analyses, with use thereafter to guide the randomization procedure. In <xref ref-type="app" rid="app1-1740774513483934">Appendix A</xref>, we investigate the linear association between number of events and posterior precision for <inline-formula id="inline-formula154-1740774513483934">
<mml:math display="inline" id="math162-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> in the context of the reference model (7) in the presence of the historical data. EHSS in this context maps the joint model’s (8) relative gain in precision for estimating the set of current model parameters, <inline-formula id="inline-formula155-1740774513483934">
<mml:math display="inline" id="math163-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="bold">λ</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, that assume commensurate prior distributions (defined conditionally upon analogous historical parameters) to a number of <italic>additional</italic> events effectively observed for control. The first interim assessment of EHSS will occur at the trial time <inline-formula id="inline-formula156-1740774513483934">
<mml:math display="inline" id="math164-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> at which at least <inline-formula id="inline-formula157-1740774513483934">
<mml:math display="inline" id="math165-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> events have been observed, <inline-formula id="inline-formula158-1740774513483934">
<mml:math display="inline" id="math166-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mi>arg</mml:mi>
<mml:mspace width="0.25em"/>
<mml:munder>
<mml:mo>min</mml:mo>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:munder>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:munderover>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:munderover>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>c</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mo>=</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula>. EHSS will then be reassessed after every <inline-formula id="inline-formula159-1740774513483934">
<mml:math display="inline" id="math167-1740774513483934">
<mml:mrow>
<mml:mi>B</mml:mi>
</mml:mrow>
</mml:math></inline-formula> additional patients enroll. Thus, the <italic>h</italic>th reassessment of EHSS will occur at trial time, <inline-formula id="inline-formula160-1740774513483934">
<mml:math display="inline" id="math168-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math></inline-formula> where <inline-formula id="inline-formula161-1740774513483934">
<mml:math display="inline" id="math169-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mi>arg</mml:mi>
<mml:mspace width="0.25em"/>
<mml:munder>
<mml:mo>min</mml:mo>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:munder>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>+</mml:mo>
<mml:mi>B</mml:mi>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mo>,</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi>h</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>2</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>3</mml:mn>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. Let <inline-formula id="inline-formula162-1740774513483934">
<mml:math display="inline" id="math170-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> denote the number of events that have occurred by trial time <inline-formula id="inline-formula163-1740774513483934">
<mml:math display="inline" id="math171-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>, <inline-formula id="inline-formula164-1740774513483934">
<mml:math display="inline" id="math172-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:munderover>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:munderover>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>c</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula>. Following section ‘EHSS’, let <inline-formula id="inline-formula165-1740774513483934">
<mml:math display="inline" id="math173-1740774513483934">
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msubsup>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula> denote the posterior precision of <inline-formula id="inline-formula166-1740774513483934">
<mml:math display="inline" id="math174-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> at the <italic>h</italic>th interim analysis under the reference model (7). Similarly, let <inline-formula id="inline-formula167-1740774513483934">
<mml:math display="inline" id="math175-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula> denote the posterior precision of <inline-formula id="inline-formula168-1740774513483934">
<mml:math display="inline" id="math176-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> at the <italic>h</italic>th interim analysis under the joint model (8). Recall that we have defined the time axis partition for analysis at time <inline-formula id="inline-formula169-1740774513483934">
<mml:math display="inline" id="math177-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> such that approximately <inline-formula id="inline-formula170-1740774513483934">
<mml:math display="inline" id="math178-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:math></inline-formula> of the observed events occur within each time axis interval. The EHSS at the <italic>h</italic>th interim analysis follows from (3) as the sum of parameter-specific EHSSs (each based upon <inline-formula id="inline-formula171-1740774513483934">
<mml:math display="inline" id="math179-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:math></inline-formula> events) for the current baseline hazards</p>
<p>
<disp-formula id="disp-formula9-1740774513483934">
<label>(9)</label>
<mml:math display="block" id="math180-1740774513483934">
<mml:mrow>
<mml:mi>EHS</mml:mi>
<mml:msub>
<mml:mrow>
<mml:mi>S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mo>max</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:munderover>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:munderover>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:mfrac>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msubsup>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>,</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mn>0</mml:mn>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula9-1740774513483934" xlink:href="10.1177_1740774513483934-eq9.tif"/>
</disp-formula>
</p>
<p>We introduced EHSS (3) in the context of a Bayesian analysis with fixed hyperparameter <inline-formula id="inline-formula172-1740774513483934">
<mml:math display="inline" id="math181-1740774513483934">
<mml:mrow>
<mml:mi>η</mml:mi>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math></inline-formula> Because we now average over the uncertainty for estimating hyperparameter <inline-formula id="inline-formula173-1740774513483934">
<mml:math display="inline" id="math182-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>, sufficient heterogeneity may result in less precision for the joint posterior inference, <inline-formula id="inline-formula174-1740774513483934">
<mml:math display="inline" id="math183-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mo>&lt;</mml:mo>
<mml:msubsup>
<mml:mrow>
<mml:mi mathvariant="script">P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>*</mml:mo>
</mml:mrow>
</mml:msubsup>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math></inline-formula>. Thus, we define <inline-formula id="inline-formula175-1740774513483934">
<mml:math display="inline" id="math184-1740774513483934">
<mml:mrow>
<mml:mi>EHS</mml:mi>
<mml:msub>
<mml:mrow>
<mml:mi>S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> to be nonnegative valued.</p>
<p>After the <italic>h</italic>th interim analysis, we seek to obtain balance between the number of patients assigned to each regimen at the <italic>end</italic> of the trial relative to <inline-formula id="inline-formula176-1740774513483934">
<mml:math display="inline" id="math185-1740774513483934">
<mml:mrow>
<mml:mi>EHS</mml:mi>
<mml:msub>
<mml:mrow>
<mml:mi>S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> in the context of a permuted-block randomization procedure with blocks of size <inline-formula id="inline-formula177-1740774513483934">
<mml:math display="inline" id="math186-1740774513483934">
<mml:mrow>
<mml:mi>B</mml:mi>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math></inline-formula> Let <inline-formula id="inline-formula178-1740774513483934">
<mml:math display="inline" id="math187-1740774513483934">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>FOX</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula179-1740774513483934">
<mml:math display="inline" id="math188-1740774513483934">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>IFL</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> denote the number of patients assigned to FOLFOX and IFL at trial time <inline-formula id="inline-formula180-1740774513483934">
<mml:math display="inline" id="math189-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, respectively. Let <inline-formula id="inline-formula181-1740774513483934">
<mml:math display="inline" id="math190-1740774513483934">
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> denote the number of remaining patients at trial time <inline-formula id="inline-formula182-1740774513483934">
<mml:math display="inline" id="math191-1740774513483934">
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, <inline-formula id="inline-formula183-1740774513483934">
<mml:math display="inline" id="math192-1740774513483934">
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mi>n</mml:mi>
<mml:mo>−</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>IFL</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>−</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>FOX</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. Following the <italic>h</italic>th interim analysis, approximately <inline-formula id="inline-formula184-1740774513483934">
<mml:math display="inline" id="math193-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>π</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi>B</mml:mi>
</mml:mrow>
</mml:math></inline-formula> of the next <inline-formula id="inline-formula185-1740774513483934">
<mml:math display="inline" id="math194-1740774513483934">
<mml:mrow>
<mml:mi>B</mml:mi>
</mml:mrow>
</mml:math></inline-formula> patients to enroll into the trial will be randomly assigned to FOLFOX and <inline-formula id="inline-formula186-1740774513483934">
<mml:math display="inline" id="math195-1740774513483934">
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>π</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>B</mml:mi>
</mml:mrow>
</mml:math></inline-formula> assigned to IFL, where <inline-formula id="inline-formula187-1740774513483934">
<mml:math display="inline" id="math196-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>π</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> is defined to satisfy the following equation</p>
<p>
<disp-formula id="disp-formula10-1740774513483934">
<label>(10)</label>
<mml:math display="block" id="math197-1740774513483934">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>FOX</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>+</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>π</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mi>EHS</mml:mi>
<mml:msub>
<mml:mrow>
<mml:mi>S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>+</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>IFL</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>π</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula10-1740774513483934" xlink:href="10.1177_1740774513483934-eq10.tif"/>
</disp-formula>
</p>
<p>Therefore, <inline-formula id="inline-formula188-1740774513483934">
<mml:math display="inline" id="math198-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>π</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> is</p>
<p>
<disp-formula id="disp-formula11-1740774513483934">
<label>(11)</label>
<mml:math display="block" id="math199-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>π</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mo>min</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:mfrac>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>EHS</mml:mi>
<mml:msub>
<mml:mrow>
<mml:mi>S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>+</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>IFL</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>−</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>FOX</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
<mml:mo>+</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula11-1740774513483934" xlink:href="10.1177_1740774513483934-eq11.tif"/>
</disp-formula>
</p>
<p>The design can accommodate alternative default allocation ratios (besides 1:1) through modification of (10) to reflect the desired sample size imbalance at the trial’s completion.</p>
</sec>
</sec>
</sec>
<sec id="section19-1740774513483934">
<title>Simulations</title>
<p>We use simulation to evaluate the frequentist properties of the proposed alternative, adaptive design of the Goldberg trial. The simulation uses the actual patient-level data from <inline-formula id="inline-formula189-1740774513483934">
<mml:math display="inline" id="math200-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mn>224</mml:mn>
</mml:mrow>
</mml:math></inline-formula> historical controls assigned to IFL in the Saltz trial. Patient accrual in the simulated trials follows the actual enrollment dates (shown in <xref ref-type="fig" rid="fig2-1740774513483934">Figure 2</xref>) for <inline-formula id="inline-formula190-1740774513483934">
<mml:math display="inline" id="math201-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>419</mml:mn>
</mml:mrow>
</mml:math></inline-formula> patients randomized to FOLFOX or IFL during the Goldberg trial. Following subsection ‘New trial’, each simulated trial proceeds as follows. Patients are randomized 1:1 to IFL and FOLFOX using permuted-block randomization with blocks of size 2 until <inline-formula id="inline-formula191-1740774513483934">
<mml:math display="inline" id="math202-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> total events are observed at time <inline-formula id="inline-formula192-1740774513483934">
<mml:math display="inline" id="math203-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>. Thereafter, the probability of assigning a new patient to FOLFOX (11) adjusts in blocks of size <inline-formula id="inline-formula193-1740774513483934">
<mml:math display="inline" id="math204-1740774513483934">
<mml:mrow>
<mml:mi>B</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>30</mml:mn>
</mml:mrow>
</mml:math></inline-formula> as a function of EHSS and the number of patients already assigned to each treatment arm. The joint commensurate prior model (8) used to compute EHSS at each interim analysis assumed spike-and-slab priors (6) for <inline-formula id="inline-formula194-1740774513483934">
<mml:math display="inline" id="math205-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>τ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>2</mml:mn>
<mml:mo>,</mml:mo><mml:mo>…</mml:mo>
</mml:mrow>
</mml:math></inline-formula> with the following hyperparameters: <inline-formula id="inline-formula195-1740774513483934">
<mml:math display="inline" id="math206-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:math></inline-formula>, <inline-formula id="inline-formula196-1740774513483934">
<mml:math display="inline" id="math207-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>u</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:math></inline-formula>, <inline-formula id="inline-formula197-1740774513483934">
<mml:math display="inline" id="math208-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="script">K</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>5000</mml:mn>
</mml:mrow>
</mml:math></inline-formula>, and <inline-formula id="inline-formula198-1740774513483934">
<mml:math display="inline" id="math209-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>5</mml:mn>
</mml:mrow>
</mml:math></inline-formula>. A final analysis occurs at time <inline-formula id="inline-formula199-1740774513483934">
<mml:math display="inline" id="math210-1740774513483934">
<mml:mrow>
<mml:mi>T</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, 51 months following initial enrollment using the joint commensurate prior model with <inline-formula id="inline-formula200-1740774513483934">
<mml:math display="inline" id="math211-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">S</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>u</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mn>5</mml:mn>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula201-1740774513483934">
<mml:math display="inline" id="math212-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>p</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>9</mml:mn>
</mml:mrow>
</mml:math></inline-formula>. The approach provides for more borrowing of strength from the historical data for computing EHSS, while facilitating slightly less borrowing when estimating the FOLFOX treatment effect, <inline-formula id="inline-formula202-1740774513483934">
<mml:math display="inline" id="math213-1740774513483934">
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, at the final analysis.</p>
<p>Frequentist properties are considered under varying magnitudes of assumed historical bias. Let <inline-formula id="inline-formula203-1740774513483934">
<mml:math display="inline" id="math214-1740774513483934">
<mml:mrow>
<mml:mover>
<mml:mi>θ</mml:mi>
<mml:mo>~</mml:mo>
</mml:mover>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">{</mml:mo>
<mml:mover>
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
<mml:mo>,</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">}</mml:mo>
</mml:mrow>
</mml:math></inline-formula> denote a set of fixed parameters characterizing a true state of the current model, where the baseline hazards, <inline-formula id="inline-formula204-1740774513483934">
<mml:math display="inline" id="math215-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula205-1740774513483934">
<mml:math display="inline" id="math216-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math></inline-formula> are defined under <inline-formula id="inline-formula206-1740774513483934">
<mml:math display="inline" id="math217-1740774513483934">
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>243</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula207-1740774513483934">
<mml:math display="inline" id="math218-1740774513483934">
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mn>243</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">]</mml:mo>
</mml:mrow>
</mml:math></inline-formula> (the AIC-optimal time axis partition for inference on the historical data alone). TTP for current patients are generated from <inline-formula id="inline-formula208-1740774513483934">
<mml:math display="inline" id="math219-1740774513483934">
<mml:mrow>
<mml:mover>
<mml:mi>θ</mml:mi>
<mml:mo>~</mml:mo>
</mml:mover>
</mml:mrow>
</mml:math></inline-formula> by shifting the log baseline hazards, <inline-formula id="inline-formula209-1740774513483934">
<mml:math display="inline" id="math220-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mover>
<mml:mi>λ</mml:mi>
<mml:mo>~</mml:mo>
</mml:mover>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, from their historical estimates in <xref ref-type="table" rid="table1-1740774513483934">Table 1</xref> by Δ100%, where <inline-formula id="inline-formula210-1740774513483934">
<mml:math display="inline" id="math221-1740774513483934">
<mml:mrow>
<mml:mover>
<mml:mi>λ</mml:mi>
<mml:mo>~</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Δ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>exp</mml:mi>
<mml:mo stretchy="false">{</mml:mo>
<mml:mo>−</mml:mo>
<mml:mn>5</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>689</mml:mn>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>Δ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">}</mml:mo>
<mml:mo>,</mml:mo>
<mml:mi>exp</mml:mi>
<mml:mo stretchy="false">{</mml:mo>
<mml:mo>−</mml:mo>
<mml:mn>4</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>858</mml:mn>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>Δ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">}</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. The historical data are assumed to be unbiased for the case where <inline-formula id="inline-formula211-1740774513483934">
<mml:math display="inline" id="math222-1740774513483934">
<mml:mrow>
<mml:mi>Δ</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:math></inline-formula>. Without loss of generality, we fix <inline-formula id="inline-formula212-1740774513483934">
<mml:math display="inline" id="math223-1740774513483934">
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:math></inline-formula>.</p>
<p>
<xref ref-type="fig" rid="fig3-1740774513483934">Figure 3</xref> plots results for mean EHSS and mean proportion of patients (out of <inline-formula id="inline-formula213-1740774513483934">
<mml:math display="inline" id="math224-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>419</mml:mn>
</mml:mrow>
</mml:math></inline-formula>) assigned to FOLFOX as functions of trial time. Each column corresponds to a different value of Δ100%, indicating relative magnitudes of assumed historical bias. Each graph in the bottom row of plots shows results for designs that initiate adaptive randomization after <inline-formula id="inline-formula214-1740774513483934">
<mml:math display="inline" id="math225-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mn>60</mml:mn>
<mml:mo>,</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mn>90</mml:mn>
<mml:mspace width="0.25em"/>
<mml:mtext>and</mml:mtext>
<mml:mspace width="0.25em"/>
<mml:mn>120</mml:mn>
</mml:mrow>
</mml:math></inline-formula> observed events. Results are shown in the top row of plots for <inline-formula id="inline-formula215-1740774513483934">
<mml:math display="inline" id="math226-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mn>60</mml:mn>
</mml:mrow>
</mml:math></inline-formula>. The plots show that increasing (decreasing) the baseline hazards leads to designs for which the initial computation of EHSS (determined by <inline-formula id="inline-formula216-1740774513483934">
<mml:math display="inline" id="math227-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>), and initiation of the AR procedure thereafter, occurs earlier (later), on average. The top row of graphs show us that the actual historical data are most commensurate, on average, with the concurrent data when Δ100% = 0% (no change) and 5%(5% increase). The joint model borrows more strength from the historical data for these two scenarios, which leads to larger initial EHSS, and increasing trends over time as more events facilitate larger relative gains in posterior precision. This induces monotonically increasing trends over time in the mean proportion of patients assigned to FOLFOX. Note that because increasing the baseline line hazards yields fewer right-censored observations, EHSS is ultimately slightly larger for Δ100% = 5% when compared to Δ100% = 0%. In addition, AR initiates earlier for Δ100% = 5%. Thus, slightly more patients, on average, are assigned to FOLFOX when Δ100% = 5%. In contrast, the graphs show smaller initial EHSS with decreasing trends over time for the scenarios where Δ100% = −10%, −5%, and 10%, leading to less allocation to FOLFOX, on average. For these three scenarios, we see that the trends over time in mean proportion of patients assigned to FOLFOX for the three choices of <inline-formula id="inline-formula217-1740774513483934">
<mml:math display="inline" id="math228-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> ultimately converge. This suggests that our adaptive design is robust among reasonable choices in the initial timing of the interim assessments of EHSS.</p>
<fig id="fig3-1740774513483934" position="float">
<label>Figure 3.</label>
<caption>
<p>Simulated mean EHSS (top row) and mean proportion of patients assigned to FOLFOX (bottom row) as functions of trial time corresponding to designs that initiate adaptive randomization after 60 (solid), 90 (dashed), and 120 (dotted) observed events. Results are shown for five magnitudes of assumed historical bias, indicating the amounts of relative change in the concurrent log baseline hazards, <inline-formula id="inline-formula218-1740774513483934">
<mml:math display="inline" id="math229-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula219-1740774513483934">
<mml:math display="inline" id="math230-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, from their historical estimates in <xref ref-type="table" rid="table1-1740774513483934">Table 1</xref>.</p>
<p>EHSS: effective historical sample size; AR: adaptive randomization; FOLFOX: oxaliplatin and infused fluorouracil plus leucovorin.</p>
</caption>
<graphic xlink:href="10.1177_1740774513483934-fig3.tif"/>
</fig>
<p>Because our simulation study uses the actual historical data (as opposed to generating data from a piecewise exponential model with parameters fixed at their estimates in <xref ref-type="table" rid="table1-1740774513483934">Table 1</xref>), the results lack symmetry around the case where the historical data are assumed to be unbiased, <inline-formula id="inline-formula220-1740774513483934">
<mml:math display="inline" id="math231-1740774513483934">
<mml:mrow>
<mml:mi>Δ</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:math></inline-formula>. The actual historical information appears to be most commensurate with accumulating concurrent information when current data are generated from the piecewise exponential model with <inline-formula id="inline-formula221-1740774513483934">
<mml:math display="inline" id="math232-1740774513483934">
<mml:mrow>
<mml:mn>0</mml:mn>
<mml:mo>&lt;</mml:mo>
<mml:mi>Δ</mml:mi>
<mml:mo>&lt;</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>05</mml:mn>
</mml:mrow>
</mml:math></inline-formula>.</p>
<p>In addition, we evaluated the adaptive design’s frequentist properties for point estimation of the FOLFOX effect, <inline-formula id="inline-formula222-1740774513483934">
<mml:math display="inline" id="math233-1740774513483934">
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, using the posterior mean at the final analysis, <inline-formula id="inline-formula223-1740774513483934">
<mml:math display="inline" id="math234-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>E</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. Specifically, we simulated expected bias and risk under squared error loss (SEL) with respect to the conditional distribution of the data, <inline-formula id="inline-formula224-1740774513483934">
<mml:math display="inline" id="math235-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>, given <inline-formula id="inline-formula225-1740774513483934">
<mml:math display="inline" id="math236-1740774513483934">
<mml:mrow>
<mml:mi>Δ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> and the actual historical data, <inline-formula id="inline-formula226-1740774513483934">
<mml:math display="inline" id="math237-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>:</p>
<p>
<disp-formula id="disp-formula12-1740774513483934">
<label>(12)</label>
<mml:math display="block" id="math238-1740774513483934">
<mml:mrow>
<mml:mtable align="right" width="80%">
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>E</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi>Δ</mml:mi>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>E</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mo>−</mml:mo>
<mml:mover>
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
<mml:mo>,</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mspace width="0.25em"/>
<mml:mtext>and</mml:mtext>
<mml:mspace width="0.25em"/>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd columnalign="right" columnspan="1">
<mml:mrow>
<mml:mspace width="0.25em"/>
<mml:msub>
<mml:mrow>
<mml:mi>E</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi>Δ</mml:mi>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>E</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>−</mml:mo>
<mml:mover>
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
<mml:mo>}</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msup>
<mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula12-1740774513483934" xlink:href="10.1177_1740774513483934-eq12.tif"/></disp-formula>
</p>
<p>Results for the adaptive designs are compared to a fixed 1:1 allocation design with analysis under the associated reference (‘no borrowing’) model and a ‘pooled’ model, which simply pools the historical and current controls and randomizes new patients to FOLFOX with probability 0.77, so that the final analysis has approximately 321 total patients (historical and current) assigned to each regimen.</p>
<p><xref ref-type="fig" rid="fig4-1740774513483934">Figure 4</xref> presents expected bias and risk under SEL for estimating <inline-formula id="inline-formula227-1740774513483934">
<mml:math display="inline" id="math239-1740774513483934">
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
</mml:math></inline-formula> as functions of Δ100%. Each column corresponds to a different value of <inline-formula id="inline-formula228-1740774513483934">
<mml:math display="inline" id="math240-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>. A total of 1000 replicated trials were simulated for each of the seven scenarios corresponding to values of Δ100% ranging from −15% to 15%. Each approach leads to an admissible estimator. Under no borrowing, <inline-formula id="inline-formula229-1740774513483934">
<mml:math display="inline" id="math241-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula> is ignored. Thus, the posterior mean of <inline-formula id="inline-formula230-1740774513483934">
<mml:math display="inline" id="math242-1740774513483934">
<mml:mrow>
<mml:mi>ξ</mml:mi>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> is unbiased. Increasing the baseline hazards results in fewer right-censored patients, which decreases risk. In contrast, the pooled design offers maximal variance reduction, and thus is associated with the largest reductions in risk at Δ100% = 0%. However, this approach precludes learning about intra-control heterogeneity, which leads to prohibitively biased estimators with sharply, uniformly increasing risk that exceeds no borrowing for |Δ100%| &gt; 2%. The adaptive design offers a compromise. For |Δ100%| &lt; 3.5%, it leads to estimators that dominate no borrowing for risk. Bias is attenuated for large values of Δ100%, leading to near replication of no borrowing risk for |Δ100%| &gt; 10%. No borrowing dominates for intermediate intra-control effects, (−10% &lt; Δ100% &lt; −3.5%) ∪ (3.5% &lt; Δ100% &lt; 10%). However, adaptive borrowing leads to considerable reductions in risk and bias when compared to naive pooling over this portion of the parameter space. The hierarchical model’s spike-and-slab hyperparameters can be adjusted to modulate risk tolerance in the presence of intermediate intra-control effects. In addition, the simulations suggest the estimator is relatively robust to the choice of <inline-formula id="inline-formula231-1740774513483934">
<mml:math display="inline" id="math243-1740774513483934">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math></inline-formula>.</p>
<fig id="fig4-1740774513483934" position="float">
<label>Figure 4.</label>
<caption>
<p>Expected bias (top row) and risk under SEL (bottom row) for estimating the FOLFOX effect, <inline-formula id="inline-formula232-1740774513483934">
<mml:math display="inline" id="math244-1740774513483934">
<mml:mrow>
<mml:mi>ξ</mml:mi>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math></inline-formula> as functions of percent change in the log baseline hazards from their historical estimates in <xref ref-type="table" rid="table1-1740774513483934">Table 1</xref>. Results are shown for three values of the number of observed events required before initiating the adaptive randomization procedure.</p>
<p>SEL: squared error loss; AR: adaptive randomization; FOLFOX: oxaliplatin and infused fluorouracil plus leucovorin; BL: baseline.</p>
</caption>
<graphic xlink:href="10.1177_1740774513483934-fig4.tif"/>
</fig>
</sec>
<sec id="section20-1740774513483934" sec-type="discussion">
<title>Discussion</title>
<p>In this article, we proposed an adaptive trial design that implements a randomization procedure for allocating patients aimed at balancing total information (concurrent and historical) among the study arms by assigning more patients to receive the novel therapy in the absence of evidence for heterogeneity among the concurrent and historical controls, and yields an estimator of the novel treatment effect that obtains desirable frequentist properties. The proposed design promises to enhance efficiency in the prospective evaluation of new therapies involving controlled clinical trials that follow recent evaluations of the control therapy in the presence of little intra-control heterogeneity without risking highly biased estimation in the presence of substantial intra-control heterogeneity.</p>
<p>The proposed adaptive trial was considered in a ‘non-sequential’ setting involving a single treatment comparison at the end of the trial. That is, the design, while sequential in assessing evidence for heterogeneity among the historical and concurrent controls, did not incorporate decision rules for early stopping for efficacy or futility. Extending the proposed adaptive trial to allow for earlier stopping is an area for potential future development. Indeed, other areas for future development are many, since they include any setting where we wish to adjust trial enrollment adaptively based on an updated estimate of how much strength may be sensibly borrowed from external data sources. For instance, when historical information is also available on the new treatment, we may have two commensurability calculations, each having their own impact on the randomization ratio (11). Alternatively, in a one-arm device safety trial, we may use commensurate priors to decide when to stop accrual based on the predictive probability of a favorable end result given the current estimate of the total effective sample size. While our approach is exclusively Bayesian, Freedman and Spiegelhalter [<xref ref-type="bibr" rid="bibr22-1740774513483934">22</xref>] have considered clinical trials that use Bayesian methods for design and frequentist methods for final analysis.</p>
</sec>
</body>
<back>
<app-group>
<app id="app1-1740774513483934">
<title>Appendix A</title>
<p>Here, we investigate the association between number of events and posterior precision for <inline-formula id="inline-formula233-1740774513483934">
<mml:math display="inline" id="math245-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> in the context of the reference model (7). We simulated 7000 data sets from a piecewise exponential probability distribution. For each simulated data set, <inline-formula id="inline-formula234-1740774513483934">
<mml:math display="inline" id="math246-1740774513483934">
<mml:mrow>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, the sample size, <inline-formula id="inline-formula235-1740774513483934">
<mml:math display="inline" id="math247-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:math></inline-formula>, and right-censoring probability, <inline-formula id="inline-formula236-1740774513483934">
<mml:math display="inline" id="math248-1740774513483934">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi>π</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>cens</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math></inline-formula>, were randomly generated from uniform distributions covering broad ranges of the sample spaces of relevance: <inline-formula id="inline-formula237-1740774513483934">
<mml:math display="inline" id="math249-1740774513483934">
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>~</mml:mo>
<mml:mi>Uniform</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>50</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>600</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula238-1740774513483934">
<mml:math display="inline" id="math250-1740774513483934">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mi>π</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>cens</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo>~</mml:mo>
<mml:mi>Uniform</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>,</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>8</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula>. Time-to-event observations were generated for each of the <inline-formula id="inline-formula239-1740774513483934">
<mml:math display="inline" id="math251-1740774513483934">
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
</mml:mrow>
</mml:math></inline-formula> patients from <inline-formula id="inline-formula240-1740774513483934">
<mml:math display="inline" id="math252-1740774513483934">
<mml:mrow>
<mml:mover>
<mml:mi>θ</mml:mi>
<mml:mo>~</mml:mo>
</mml:mover>
</mml:mrow>
</mml:math></inline-formula> containing baseline hazards fixed at their corresponding historical estimates in <xref ref-type="table" rid="table1-1740774513483934">Table 1</xref>, <inline-formula id="inline-formula241-1740774513483934">
<mml:math display="inline" id="math253-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mo>−</mml:mo>
<mml:mn>5</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>689</mml:mn>
</mml:mrow>
</mml:math></inline-formula> and <inline-formula id="inline-formula242-1740774513483934">
<mml:math display="inline" id="math254-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mo>−</mml:mo>
<mml:mn>4</mml:mn>
<mml:mo>.</mml:mo>
<mml:mn>858</mml:mn>
</mml:mrow>
</mml:math></inline-formula>, and treatment effect <inline-formula id="inline-formula243-1740774513483934">
<mml:math display="inline" id="math255-1740774513483934">
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mi>ξ</mml:mi>
</mml:mrow>
<mml:mo>~</mml:mo>
</mml:mover>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:math></inline-formula>. For each data set, we recorded the number of events observed in the initial partition interval, and fit the reference model (7) to obtain the associated posterior precision of <inline-formula id="inline-formula244-1740774513483934">
<mml:math display="inline" id="math256-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mi mathvariant="script">D</mml:mi>
</mml:mrow>
</mml:math></inline-formula>. The results in <xref ref-type="fig" rid="fig5-1740774513483934">Figure 5</xref> reveal a strong linear association (Pearson correlation of 0.996) among posterior precision and number of observed events for the considered portion of the parameter space.</p>
<fig id="fig5-1740774513483934" position="float">
<label>Figure 5.</label>
<caption>
<p>Scatterplot of simulation results. Each dot depicts the number of events (<italic>y</italic>-axis) as a function of posterior precision of <inline-formula id="inline-formula245-1740774513483934">
<mml:math display="inline" id="math257-1740774513483934">
<mml:mrow>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>λ</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi mathvariant="script">D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math></inline-formula> (<italic>x</italic>-axis) under the reference model (7).</p>
</caption>
<graphic xlink:href="10.1177_1740774513483934-fig5.tif"/>
</fig>
</app>
</app-group>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The work of the first author was supported in part by the University of Texas MD Anderson Cancer Center Support Grant NIH P30 CA016672. The work of the second author was supported in part by National Cancer Institute grant 1-R01-CA157458-01A1. The work of the third author was supported in part by NCI grant CA25224.</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>None declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1740774513483934">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bretz</surname><given-names>F</given-names></name>
<name><surname>Koenig</surname><given-names>F</given-names></name>
<name><surname>Brannath</surname><given-names>W</given-names></name>
<name><surname>Glimm</surname><given-names>E</given-names></name>
<name><surname>Posch</surname><given-names>M</given-names></name>
</person-group>. <article-title>Adaptive designs for confirmatory clinical trials</article-title>. <source>Stat Med</source> <year>2009</year>; <volume>28</volume>: <fpage>1181</fpage>–<lpage>217</lpage>.</citation>
</ref>
<ref id="bibr2-1740774513483934">
<label>2.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Berry</surname><given-names>SM</given-names></name>
<name><surname>Carlin</surname><given-names>BP</given-names></name>
<name><surname>Lee</surname><given-names>JJ</given-names></name>
<name><surname>Müller</surname><given-names>P</given-names></name>
</person-group>. <source>Bayesian Adaptive Methods for Clinical Trials</source>. <publisher-name>Chapman and Hall/CRC Press</publisher-name>, <publisher-loc>Boca Raton, FL</publisher-loc>, <year>2010</year>.</citation>
</ref>
<ref id="bibr3-1740774513483934">
<label>3.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Friedman</surname><given-names>L</given-names></name>
<name><surname>Furberg</surname><given-names>C</given-names></name>
<name><surname>DeMets</surname><given-names>DL</given-names></name>
</person-group>. <source>Fundamentals of Clinical Trials</source> (<edition>3rd edn</edition>). <publisher-name>Springer-Verlag</publisher-name>, <publisher-loc>New York</publisher-loc>, <year>1998</year>.</citation>
</ref>
<ref id="bibr4-1740774513483934">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pocock</surname><given-names>SJ</given-names></name>
<name><surname>Simon</surname><given-names>R</given-names></name>
</person-group>. <article-title>Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial</article-title>. <source>Biometrics</source> <year>1975</year>; <volume>31</volume>: <fpage>103</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr5-1740774513483934">
<label>5.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>G</given-names></name>
<name><surname>LeBlanc</surname><given-names>M</given-names></name>
<name><surname>Liu</surname><given-names>PY</given-names></name>
<name><surname>Crowley</surname><given-names>J</given-names></name>
</person-group>. <article-title>On use of covariates in randomization and analysis of clinical trials</article-title>. In <person-group person-group-type="editor">
<name><surname>Crowley</surname><given-names>J</given-names></name>
<name><surname>Hoering</surname><given-names>A</given-names></name>
</person-group> (eds). <source>Handbook of Statistics in Clinical Oncology</source> (<edition>3rd edn</edition>). <publisher-name>Chapman and Hall/CRC Press</publisher-name>, <publisher-loc>Boca Raton, FL</publisher-loc>, <year>2011</year>, pp. <fpage>185</fpage>–<lpage>189</lpage>.</citation>
</ref>
<ref id="bibr6-1740774513483934">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Berry</surname><given-names>DA</given-names></name>
<name><surname>Eick</surname><given-names>S</given-names></name>
</person-group>. <article-title>Adaptive assignment versus balanced randomization in clinical trials: A decision analysis</article-title>. <source>Stat Med</source> <year>1995</year>; <volume>14</volume>: <fpage>231</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr7-1740774513483934">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thall</surname><given-names>PF</given-names></name>
<name><surname>Wathen</surname><given-names>JK</given-names></name>
</person-group>. <article-title>Practical Bayesian adaptive randomisation in clinical trials</article-title>. <source>Eur J Cancer</source> <year>2007</year>; <volume>43</volume>: <fpage>859</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr8-1740774513483934">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>X</given-names></name>
<name><surname>Liu</surname><given-names>S</given-names></name>
<name><surname>Kim</surname><given-names>ES</given-names></name>
<name><surname>Herbst</surname><given-names>RS</given-names></name>
<name><surname>Lee</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Bayesian adaptive design for targeted therapy development in lung cancer – A step toward personalized medicine</article-title>. <source>Clin Trials</source> <year>2008</year>; <volume>5</volume>: <fpage>181</fpage>–<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr9-1740774513483934">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>X</given-names></name>
<name><surname>Ning</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
</person-group> <source>et al</source>. <article-title>Using short-term response information to facilitate adaptive randomization for survival clinical trials</article-title>. <source>Stat Med</source> <year>2009</year>; <volume>28</volume>: <fpage>1680</fpage>–<lpage>89</lpage>.</citation>
</ref>
<ref id="bibr10-1740774513483934">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>JJ</given-names></name>
<name><surname>Gu</surname><given-names>X</given-names></name>
<name><surname>Liu</surname><given-names>S</given-names></name>
</person-group>. <article-title>Bayesian adaptive randomization designs for targeted agent development</article-title>. <source>Clin Trials</source> <year>2010</year>; <volume>7</volume>: <fpage>584</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr11-1740774513483934">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Korn</surname><given-names>EL</given-names></name>
<name><surname>Freidlin</surname><given-names>B</given-names></name>
</person-group>. <article-title>Outcome-adaptive randomization: Is it useful?</article-title> <source>J Clin Oncol</source> <year>2011</year>; <volume>29</volume>: <fpage>771</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr12-1740774513483934">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pocock</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>The combination of randomized and historical controls in clinical trials</article-title>. <source>J Chronic Dis</source> <year>1976</year>; <volume>29</volume>: <fpage>175</fpage>–<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr13-1740774513483934">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goldberg</surname><given-names>RM</given-names></name>
<name><surname>Sargent</surname><given-names>DJ</given-names></name>
<name><surname>Morton</surname><given-names>RF</given-names></name>
</person-group> <source>et al</source>. <article-title>A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer</article-title>. <source>J Clin Oncol</source> <year>2004</year>; <volume>22</volume>: <fpage>23</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr14-1740774513483934">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saltz</surname><given-names>LB</given-names></name>
<name><surname>Cox</surname><given-names>JV</given-names></name>
<name><surname>Blanke</surname><given-names>C</given-names></name>
<etal/>
</person-group>.; <article-title>The Irinoteca Study Group. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer</article-title>. <source>N Engl J Med</source> <year>2000</year>; <volume>343</volume>: <fpage>905</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr15-1740774513483934">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hobbs</surname><given-names>BP</given-names></name>
<name><surname>Sargent</surname><given-names>DJ</given-names></name>
<name><surname>Carlin</surname><given-names>BP</given-names></name>
</person-group>. <article-title>Commensurate priors for incorporating historical information in clinical trials using general and generalized linear models</article-title>. <source>Bayesian Anal</source> <year>2012</year>; <volume>7</volume>: <fpage>639</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr16-1740774513483934">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hobbs</surname><given-names>BP</given-names></name>
<name><surname>Carlin</surname><given-names>BP</given-names></name>
<name><surname>Mandekar</surname><given-names>SJ</given-names></name>
<name><surname>Sargent</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials</article-title>. <source>Biometrics</source> <year>2011</year>; <volume>67</volume>: <fpage>1047</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr17-1740774513483934">
<label>17.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Ibrahim</surname><given-names>JG</given-names></name>
<name><surname>Chen</surname><given-names>MH</given-names></name>
<name><surname>Sinha</surname><given-names>D</given-names></name>
</person-group>. <source>Bayesian Survival Analysis</source>. <publisher-name>Springer-Verlag</publisher-name>, <publisher-loc>New York</publisher-loc>, <year>2001</year>.</citation>
</ref>
<ref id="bibr18-1740774513483934">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morita</surname><given-names>S</given-names></name>
<name><surname>Thall</surname><given-names>PF</given-names></name>
<name><surname>Müller</surname><given-names>P</given-names></name>
</person-group>. <article-title>Determining the effective sample size of a parametric prior</article-title>. <source>Biometrics</source> <year>2008</year>; <volume>64</volume>: <fpage>595</fpage>–<lpage>602</lpage>.</citation>
</ref>
<ref id="bibr19-1740774513483934">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mitchell</surname><given-names>TJ</given-names></name>
<name><surname>Beauchamp</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Bayesian variable selection in linear regression</article-title>. <source>J Am Stat Assoc</source> <year>1988</year>; <volume>83</volume>: <fpage>1023</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr20-1740774513483934">
<label>20.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Klein</surname><given-names>JP</given-names></name>
<name><surname>Moeschberger</surname><given-names>ML</given-names></name>
</person-group>. <source>Survival Analysis: Techniques for Censored and Truncated Data</source> (<edition>2nd edn</edition>). <publisher-name>Springer-Verlag</publisher-name>, <publisher-loc>New York</publisher-loc>, <year>2003</year>.</citation>
</ref>
<ref id="bibr21-1740774513483934">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matts</surname><given-names>JP</given-names></name>
<name><surname>Lachin</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Properties of permuted-block randomization in clinical trials</article-title>. <source>Control Clin Trials</source> <year>1988</year>; <volume>9</volume>: <fpage>327</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr22-1740774513483934">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Freedman</surname><given-names>LS</given-names></name>
<name><surname>Spiegelhalter</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>The assessment of subjective opinion and its use in relation to stopping rules for clinical trials</article-title>. <source>Statistician</source> <year>1983</year>; <volume>32</volume>: <fpage>153</fpage>–<lpage>60</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>